---
layout: page
title: MPEP Patent Appilcation Manual
image:
  feature: /wide/transmission-patent-gray-blueprint.jpg
---
   <head>
      <title>709-</title>
      <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
</head>
      <li><a href="index.html">Manual of Patent Examining Procedure</a></li>
      <li><a href="mpep-0700.html"><span>Chapter 0700</span></a></li>
      <li><span>Section 709</span></li>  </ul>
      <div id="yui-main">
         <div class="yui-b">
            <div class="yui-g">  <div xmlns:bf="http://www.uspto.gov/bf" id="article">
               <div>
                  <div xmlns="" class="Section" id="d0e78325">
                     <h1 class="page-title">709
                        &nbsp;&nbsp;
                        Suspension of Action  [R-11.2013]
                     </h1>
                     <div id="d0e78329" class="CFR">
                        <h4 class="CFR"><i>37&nbsp;C.F.R.&nbsp;1.103 &nbsp;
                              
                              
                              
                              Suspension of action by the Office.</i></h4>
                        <ul style="list-style-type: none;">
                           <li id="d0e78334" class="nobull">(a) <i>Suspension for cause</i>. On request of the
                              applicant, the Office may grant a suspension of action by the Office under this
                              paragraph for good and sufficient cause. The Office will not suspend action if
                              a reply by applicant to an Office action is outstanding. Any petition for
                              suspension of action under this paragraph must specify a period of suspension
                              not exceeding six months. Any petition for suspension of action under this
                              paragraph must also include:
                              <ul style="list-style-type: none;">
                                 <li id="" class="nobull">
                                    <p id=""></p>
                                 </li>
                                 <li id="d0e78340" class="nobull">(1) A showing of good and
                                    sufficient cause for suspension of action; and
                                 </li>
                                 <li id="d0e78344" class="nobull">(2) The fee set forth in
                                    <b><a href="mpep-0010-title-page.html#d0e315199">§ 1.17(g)</a></b>, unless
                                    such cause is the fault of the Office.
                                 </li>
                              </ul>
                           </li>
                           <li id="d0e78351" class="nobull">(b) <i>Limited suspension of action in a continued
                                 prosecution application (CPA) filed under § 1.53(d)</i>. On request of
                              the applicant, the Office may grant a suspension of action by the Office under
                              this paragraph in a continued prosecution application filed under
                              <b><a href="mpep-9020-appx-r.html#d0e318681">§ 1.53(d)</a></b> for a period not
                              exceeding three months. Any request for suspension of action under this
                              paragraph must be filed with the request for an application filed under
                              <b><a href="mpep-9020-appx-r.html#d0e318681">§ 1.53(d)</a></b>, specify the
                              period of suspension, and include the processing fee set forth in
                              <b><a href="mpep-0010-title-page.html#d0e315199">§ 1.17(i)</a></b>.
                           </li>
                           <li id="d0e78366" class="nobull">(c) <i>Limited suspension of action after a request for
                                 continued application (RCE) under § 1.114</i>. On request of the
                              applicant, the Office may grant a suspension of action by the Office under this
                              paragraph after the filing of a request for continued examination in compliance
                              with <b><a href="mpep-9020-appx-r.html#d0e322625">§ 1.114</a></b> for a period not
                              exceeding three months. Any request for suspension of action under this
                              paragraph must be filed with the request for continued examination under
                              <b><a href="mpep-9020-appx-r.html#d0e322625">§ 1.114</a></b>, specify the period
                              of suspension, and include the processing fee set forth in <b><a href="mpep-0010-title-page.html#d0e315199">§
                                    1.17(i)</a></b>.
                           </li>
                           <li id="d0e78381" class="nobull">(d) <i>Deferral of examination</i>. On request of the
                              applicant, the Office may grant a deferral of examination under the conditions
                              specified in this paragraph for a period not extending beyond three years from
                              the earliest filing date for which a benefit is claimed under title 35, United
                              States Code. A request for deferral of examination under this paragraph must
                              include the publication fee set forth in <b><a href="mpep-9020-appx-r.html#d0e315894">§ 1.18(d)</a></b>
                              and the processing fee set forth in <b><a href="mpep-0010-title-page.html#d0e315199">§ 1.17(i)</a></b>.
                              A request for deferral of examination under this paragraph will not be granted
                              unless:
                              <ul style="list-style-type: none;">
                                 <li id="" class="nobull">
                                    <p id=""></p>
                                 </li>
                                 <li id="d0e78393" class="nobull">(1) The application is an
                                    original utility or plant application filed under <b><a href="mpep-9020-appx-r.html#d0e318681">§
                                          1.53(b)</a></b> or resulting from entry of an international
                                    application into the national stage after compliance with
                                    <b><a href="mpep-9020-appx-r.html#d0e329467">§&nbsp;1.495</a></b>;
                                 </li>
                                 <li id="d0e78403" class="nobull">(2) The applicant has not
                                    filed a nonpublication request under <b><a href="mpep-9020-appx-r.html#d0e325295">§
                                          1.213(a)</a></b>, or has filed a request under
                                    <b><a href="mpep-9020-appx-r.html#d0e325295">§ 1.213(b) </a></b>to rescind
                                    a previously filed nonpublication request;
                                 </li>
                                 <li id="d0e78413" class="nobull">(3) The application is in
                                    condition for publication as provided in <b><a href="mpep-9020-appx-r.html#d0e325182">§
                                          1.211(c)</a></b>; and
                                 </li>
                                 <li id="d0e78420" class="nobull">(4) The Office has not
                                    issued either an Office action under <b><a href="mpep-9015-appx-l.html#d0e303187">35 U.S.C.
                                          132</a></b> or a notice of allowance under
                                    <b><a href="mpep-9015-appx-l.html#d0e303440">35 U.S.C.
                                          151</a></b>.
                                 </li>
                              </ul>
                           </li>
                           <li id="d0e78430" class="nobull">(e) <i>Notice of suspension on initiative of the
                                 Office</i>. The Office will notify applicant if the Office suspends
                              action by the Office on an application on its own initiative.
                           </li>
                           <li id="d0e78436" class="nobull">(f) <i> Suspension of action for public safety or
                                 defense.</i> The Office may suspend action by the Office by order of
                              the Director if the following conditions are met:
                              <ul style="list-style-type: none;">
                                 <li id="" class="nobull">
                                    <p id=""></p>
                                 </li>
                                 <li id="d0e78442" class="nobull">(1) The application is
                                    owned by the United States;
                                 </li>
                                 <li id="d0e78446" class="nobull">(2) Publication of the
                                    invention may be detrimental to the public safety or defense;
                                    and
                                 </li>
                                 <li id="d0e78450" class="nobull">(3) The appropriate
                                    department or agency requests such suspension.
                                 </li>
                              </ul>
                           </li>
                        </ul>
                     </div>
                     <p id="d0e78463">Suspension of action (<b><a href="mpep-9020-appx-r.html#d0e321982">37 CFR
                              1.103</a></b>) should not be confused with extension of time for reply
                        (<b><a href="mpep-9020-appx-r.html#d0e323655">37
                              CFR 1.136</a></b>). It is to be noted that a suspension of action applies to
                        an impending Office action by the examiner whereas an extension of time for reply applies
                        to&nbsp;action by the applicant. In other words, the action cannot be suspended in an
                        application which contains an outstanding Office action or requirement awaiting reply by
                        the applicant. It is only the action by the examiner which can be suspended under
                        <b><a href="mpep-9020-appx-r.html#d0e321982">37 CFR
                              1.103</a></b>. 
                     </p>
                     <p id="d0e78475">Suspension of action under
                        <b><a href="mpep-9020-appx-r.html#d0e321982">37 CFR
                              1.103(a)-(d)</a></b> at the applicant’s request will cause a reduction in
                        patent term adjustment accumulated (if any) under <b><a href="mpep-9020-appx-r.html#d0e331320">37 CFR 1.703</a></b>. The
                        reduction is equal to the number of days beginning on the date a request for suspension of
                        action was filed and ending on the date of the termination of the suspension. See
                        <b><a href="mpep-9020-appx-r.html#d0e331597">37 CFR
                              1.704(c)(1)</a></b>.
                     </p>
                     <div class="Section">
                        <h2 class="section1" id="d0e78487">I.
                           &nbsp;&nbsp;REQUEST BY THE APPLICANT
                        </h2>
                        <table id="d0e78493">
                           <caption></caption>
                           <thead id="d0e78505">
                              <tr id="d0e78507" style="vertical-align:top">
                                 <th id="d0e78509">Request, 37 CFR Section</th>
                                 <th id="d0e78512">Requirement</th>
                                 <th id="d0e78515">Fee(s), 37 CFR Section</th>
                                 <th id="d0e78518">Maximum length of Suspension</th>
                              </tr>
                           </thead>
                           <tbody id="d0e78523" style="vertical-align:top">
                              <tr id="d0e78525" style="vertical-align:top">
                                 <td id="d0e78527">&nbsp;<b><a href="mpep-9020-appx-r.html#d0e321982">1.103(a)</a></b></td>
                                 <td id="d0e78533">Petition with a showing of good and
                                    sufficient cause.
                                 </td>
                                 <td id="d0e78536"><b><a href="mpep-0010-title-page.html#d0e315199">1.17(g)</a></b></td>
                                 <td id="d0e78541">6 months</td>
                              </tr>
                              <tr id="d0e78545" style="vertical-align:top">
                                 <td id="d0e78547">&nbsp;<b><a href="mpep-9020-appx-r.html#d0e321982">1.103(b)</a></b></td>
                                 <td id="d0e78553">Request at the time of filing a CPA</td>
                                 <td id="d0e78556"><b><a href="mpep-0010-title-page.html#d0e315199">1.17(i)</a></b></td>
                                 <td id="d0e78561">3 months</td>
                              </tr>
                              <tr id="d0e78565" style="vertical-align:top">
                                 <td id="d0e78567">&nbsp;<b><a href="mpep-9020-appx-r.html#d0e321982">1.103(c)</a></b></td>
                                 <td id="d0e78573">Request at the time of filing an RCE</td>
                                 <td id="d0e78576"><b><a href="mpep-0010-title-page.html#d0e315199">1.17(i)</a></b></td>
                                 <td id="d0e78581">3 months</td>
                              </tr>
                              <tr id="d0e78585" style="vertical-align:top">
                                 <td id="d0e78587">&nbsp;<b><a href="mpep-9020-appx-r.html#d0e321982">1.103(d)</a></b></td>
                                 <td id="d0e78593">See below in “Deferral of
                                    Examination”
                                 </td>
                                 <td id="d0e78596"><b><a href="mpep-0010-title-page.html#d0e315199">1.17(i)</a></b> &amp;
                                    <b><a href="mpep-9020-appx-r.html#d0e315894">1.18(d)</a></b></td>
                                 <td id="d0e78604">3 yrs. from earliest filing date for which a
                                    benefit is claimed under Title 35.
                                 </td>
                              </tr>
                           </tbody>
                        </table>
                        <div class="Section">
                           <h2 class="section2" id="d0e78612">A.
                              &nbsp;&nbsp;Petition Under 37 CFR 1.103(a) With a Showing of Good and
                              Sufficient Cause
                           </h2>
                           <p id="d0e78619">A request that action in an
                              application be delayed will be granted only under the provisions of <b><a href="mpep-9020-appx-r.html#d0e321982">37 CFR
                                    1.103</a></b>, which provides for “Suspension of Action.” A petition
                              for suspension of action under <b><a href="mpep-9020-appx-r.html#d0e321982">37 CFR 1.103(a)</a></b>
                              must:
                           </p>
                           <div id="d0e78628" class="List">
                              <ul style="list-style-type: none;">
                                 <li id="d0e78629" class="nobull">(A) be presented as a
                                    separate paper; 
                                 </li>
                                 <li id="d0e78633" class="nobull">(B) be accompanied by the
                                    petition fee set forth in <b><a href="mpep-0010-title-page.html#d0e315199">37 CFR
                                          1.17(g)</a></b>; 
                                 </li>
                                 <li id="d0e78640" class="nobull">(C) request a specific and
                                    reasonable period of suspension not greater than 6 months; and
                                    
                                 </li>
                                 <li id="d0e78644" class="nobull">(D) present good and
                                    sufficient reasons why the suspension is necessary. 
                                 </li>
                              </ul>
                           </div>
                           <p id="d0e78648">If the requirements of
                              <b><a href="mpep-9020-appx-r.html#d0e321982">37 CFR 1.103(a)</a></b> are not met, applicants should expect that
                              their applications, whether new or amended, will be taken up for action by the
                              examiner in the order provided in <b><a href="s708.html#d0e76229">MPEP § 708</a></b>, Order of
                              Examination.
                           </p>
                           <p id="d0e78657">A petition for suspension of
                              action to allow applicant time to submit an information disclosure statement will be
                              denied as failing to present good and sufficient reasons, since <b><a href="mpep-9020-appx-r.html#d0e321609">37 CFR
                                    1.97</a></b> provides adequate recourse for the timely submission of
                              prior art for consideration by the examiner.
                           </p>
                           <p id="d0e78663">In new applications, the mere
                              inclusion in the transmittal form letter of a request that action be delayed cannot
                              be relied upon to avoid immediate action in the application. However, applicant may
                              consider filing a request for deferral of examination under 37 CFR 1.103(d) (see
                              below for the requirements). Applicants should be aware of the possibility of
                              requesting suspension of action by the Office under 37 CFR 1.103(b) or (c) for a
                              period not exceeding three months at the time of filing a continued prosecution
                              application (CPA) under 37 CFR 1.53(d) if the application is a design application, or
                              a request for continued examination (RCE) under 37 CFR 1.114. Note that effective
                              July 14, 2003, CPA practice does not apply to utility and plant applications. Many
                              Technology Center (TC) art units and examiners have short pendency to first action,
                              and new applications may be taken up for action before preliminary amendments are
                              filed in those applications. Where a preliminary amendment and petition to suspend
                              action have been filed, it would be helpful to telephone the examiner in that regard
                              to avoid having the amendment and the first Office action cross in the mail. The
                              following form paragraphs should be used to notify the grant or denial of the
                              petition under <b><a href="mpep-9020-appx-r.html#d0e321982">37&nbsp;CFR 1.103(a)</a></b>:
                           </p>
                           <div class="formPara"><a name="fp7.54"></a><h1 class="page-title">¶ 7.54
                                 &nbsp;&nbsp;
                                 Suspension of Action, Applicant’s Request
                              </h1>
                              <p id="fp-pt-d365e9">Pursuant to applicant’s request filed on <b id="">[1]</b>, action by the Office is suspended on this application under <b><a href="mpep-9020-appx-r.html#d0e321982">37 CFR 1.103(a)</a></b> for a period of <b id="">[2]</b> months.  At the end of this period, applicant is required to notify the examiner and request continuance of prosecution or
                                 a further suspension.  See  <b><a href="s709.html#d0e78325">MPEP § 709</a></b>.
                              </p>
                              <h3>Examiner Note:</h3>  <ul style="list-style-type: none;">
                              <li class="nobull">1. Maximum period for suspension is 6 months.</li>
                              <li class="nobull">2. Only the Technology Center Director can grant second or subsequent suspensions.  See  <b><a href="s1003.html#d0e118308">MPEP § 1003</a></b>.  Such approval must appear on the Office letter.
                              </li>  </ul>
                           </div>
                           <div class="formPara"><a name="fp7.56"></a><h1 class="page-title">¶ 7.56
                                 &nbsp;&nbsp;
                                 Request for Suspension, Denied, Outstanding Office Action  
                              </h1>
                              <p id="fp-pt-d368e9">Applicant’s request filed <b id="">[1]</b>, for suspension of action in this application under <b><a href="mpep-9020-appx-r.html#d0e321982">37 CFR 1.103(a)</a></b>, is denied as being improper.  Action cannot be suspended in an application awaiting a reply by the applicant.  See  <b><a href="s709.html#d0e78325">MPEP § 709</a></b>.
                              </p>
                           </div>
                           <p id="d0e78749">A supplemental reply will be
                              entered if it is filed within the period during which action is suspended by the
                              Office under <b><a href="mpep-9020-appx-r.html#d0e321982">37 CFR 1.103(a)</a></b>. See
                              <b><a href="s714.html#d0e87038">MPEP
                                    § 714.03(a)</a></b> regarding supplemental reply.
                           </p>
                        </div>
                        <div class="Section">
                           <h2 class="section2" id="d0e78758">B.
                              &nbsp;&nbsp;Request for Suspension Under 37 CFR 1.103(b) or
                              (c)
                           </h2>
                           <p id="d0e78765"> Applicants may request a
                              suspension of action by the Office under <b><a href="mpep-9020-appx-r.html#d0e321982">37 CFR 1.103(b) or
                                    (c)</a></b> for a period not exceeding three months in a continued
                              prosecution application (CPA) filed under <b><a href="mpep-9020-appx-r.html#d0e318681">37 CFR 1.53(d)</a></b> if
                              the application is a design application, or in a continued examination (RCE) filed
                              under <b><a href="mpep-9020-appx-r.html#d0e322625">37 CFR 1.114</a></b>. The request for
                              suspension must be filed at the time of filing of the CPA or RCE. 
                           </p>
                           <p id="d0e78777">A supplemental reply will be
                              entered if it is filed within the period during which action is suspended by the
                              Office under <b><a href="mpep-9020-appx-r.html#d0e321982">37 CFR 1.103(c)</a></b>. See
                              <b><a href="s714.html#d0e87038">MPEP
                                    § 714.03(a)</a></b> regarding supplemental reply.
                           </p>
                           <div class="Section">
                              <h3 class="section1" id="d0e78786">1. &nbsp;&nbsp;Requirements</h3>
                              <p id="d0e78790"> The Office will not grant the
                                 requested suspension of action unless the following requirements are met: 
                              </p>
                              <div id="d0e78793" class="List">
                                 <ul style="list-style-type: none;">
                                    <li id="d0e78794" class="nobull">(A) the request must be
                                       filed with the filing of a design CPA or an RCE (applicants may use the
                                       check box provided on the transmittal form PTO/SB/29 or PTO/SB/30, or
                                       submit the request on a separate paper);
                                       <ul style="list-style-type: none;">
                                          <li id="" class="nobull">
                                             <p id=""></p>
                                          </li>
                                          <li id="d0e78798" class="nobull">(1) if the request
                                             is filed with an RCE, the RCE must be in compliance with
                                             <b><a href="mpep-9020-appx-r.html#d0e322625">37 CFR 1.114</a></b>,
                                             i.e., the RCE must be accompanied by a submission and the fee set
                                             forth in <b><a href="mpep-0010-title-page.html#d0e315199">37 CFR 1.17(e)</a></b>.
                                             Note that the payment of the RCE filing fee may not be deferred and
                                             the request for suspension cannot substitute for the
                                             submission;
                                          </li>
                                          <li id="d0e78808" class="nobull">(2) if the request
                                             is filed with a CPA, a filing date must be assigned to the
                                             CPA;
                                          </li>
                                       </ul>
                                    </li>
                                    <li id="d0e78812" class="nobull">(B) the request should
                                       specify the period of suspension in a whole number of months (maximum of
                                       3 months). If the request specifies no period of suspension or a period
                                       of suspension that exceeds 3 months, the Office will assume that a
                                       3-month suspension is requested; and
                                    </li>
                                    <li id="d0e78816" class="nobull">(C) the request must
                                       include the processing fee set forth in 37 CFR 1.17(i).
                                    </li>
                                 </ul>
                              </div>
                           </div>
                           <div class="Section">
                              <h3 class="section1" id="d0e78820">2. &nbsp;&nbsp;Missing Parts for the CPA (Filing Date
                                 Granted)
                              </h3>
                              <p id="d0e78824">If the Office assigns a filing
                                 date to the design CPA, the request for suspension will be processed, even if the
                                 CPA was not accompanied by the CPA basic filing fee, the search fee, and the
                                 examination fee. The suspension request acts to suspend a first Office action by
                                 the examiner but will not affect the processing of the CPA for a missing part. The
                                 applicant will be given a notice that provides a time period of 2 months from the
                                 date of the notification to pay the CPA basic filing fee, the search fee, the
                                 examination fee, and the surcharge set forth in <b><a href="mpep-9020-appx-r.html#d0e314702">37&nbsp;CFR
                                       1.16(f)</a></b>. Applicant must pay the CPA basic filing fee, the
                                 search fee, the examination fee, and the surcharge within 2 months to avoid the
                                 abandonment of the CPA. Pursuant to applicant’s request for suspension, the action
                                 by the Office will be suspended on the CPA for the period requested by the
                                 applicant, starting on the filing date of the CPA.
                              </p>
                           </div>
                           <div class="Section">
                              <h3 class="section1" id="d0e78830">3. &nbsp;&nbsp;Improper RCE or CPA (No Filing Date Granted)</h3>
                              <p id="d0e78834">If the CPA or the RCE is
                                 improper (e.g., a filing date was not accorded in the CPA or the RCE was filed
                                 without a submission or the RCE fee), the Office will not recognize the request
                                 for suspension, and action by the Office will not be suspended. A notice of
                                 improper CPA or RCE will be sent to applicant as appropriate. The time period set
                                 in the previous Office communication (e.g., a final Office action or a notice of
                                 allowance) continues to run from the mailing date of that communication. If
                                 applicant subsequently files another RCE, the request for suspension should be
                                 resubmitted to ensure that the Office processes the request for suspension
                                 properly. The request for suspension of action will not be processed until the
                                 Office accords a filing date to the CPA or receives a proper RCE in compliance
                                 with <b><a href="mpep-9020-appx-r.html#d0e322625">37&nbsp;CFR 1.114</a></b>.
                              </p>
                           </div>
                           <div class="Section">
                              <h3 class="section1" id="d0e78840">4. &nbsp;&nbsp;Improper Request for Suspension</h3>
                              <p id="d0e78844">If the CPA or the RCE is
                                 properly filed, but the request for suspension is improper (e.g., the request for
                                 suspension was filed untimely or without the processing fee set forth in
                                 <b><a href="mpep-0010-title-page.html#d0e315199">37 CFR 1.17(i)</a></b>), action by the
                                 Office will not be suspended on the application. The Office will process the CPA
                                 or RCE and place the application on the examiner’s docket. The examiner will
                                 notify the applicant of the denial of the request in the next Office communication
                                 using the following form paragraph:
                              </p>
                              <div class="formPara"><a name="fp7.56.01"></a><h1 class="page-title">¶ 7.56.01
                                    &nbsp;&nbsp;
                                    Request for Suspension of Action under 37 CFR <b><a href="mpep-9020-appx-r.html#d0e321982">1.103</a></b>, Denied   
                                 </h1>
                                 <p id="fp-pt-d369e12">Applicant’s request filed <b id="">[1],</b> for suspension of action in this application under 37 CFR <b><a href="mpep-9020-appx-r.html#d0e321982">1.103(b)</a></b> or (c) is denied as being improper. The request was (1) not filed at the time of filing a CPA or RCE, and/or (2) not accompanied
                                    by the requisite fee as set forth in 37 CFR <b><a href="mpep-0010-title-page.html#d0e315199">1.17(i)</a></b>. See MPEP § <b><a href="s709.html#d0e78325">709</a></b>.
                                 </p>
                                 <h3>Examiner Note:</h3>
                                 <p id="fp-pt-d369e29">In bracket 1, insert the filing date of the request for suspension of action.</p>
                              </div>
                           </div>
                           <div class="Section">
                              <h3 class="section1" id="d0e78893">5. &nbsp;&nbsp;Proper Request for Suspension</h3>
                              <p id="d0e78897">If the CPA or the RCE and the
                                 request for suspension of action are proper, the Office’s technical support staff
                                 will process the CPA or RCE, and the request for suspension of action. A
                                 notification of the approval of the request for suspension will be sent to the
                                 applicant. The application will be placed in suspension status until the end of
                                 the suspension period. The suspension request acts to suspend a first Office
                                 action by the examiner. Once the suspension period has expired, the application
                                 will be placed on the examiner’s docket for further prosecution.
                              </p>
                           </div>
                        </div>
                        <div class="Section">
                           <h2 class="section2" id="d0e78900">C.
                              &nbsp;&nbsp;Request for Deferral of Examination Under 37&nbsp;CFR
                              1.103(d)
                           </h2>
                           <p id="d0e78904">In new applications, applicants
                              may request a deferral of examination under <b><a href="mpep-9020-appx-r.html#d0e321982">37 CFR 1.103(d)</a></b>
                              for a period not extending beyond three years from the earliest filing date for which
                              a benefit is claimed under <b><a href="mpep-9015-appx-l.html#d0e302921">35 U.S.C. 119(a)-(d), (e), (f)</a></b>,
                              <b><a href="mpep-0010-title-page.html#d0e303023">120</a></b>, <b><a href="mpep-9015-appx-l.html#d0e303040">121</a></b>, or <b><a href="mpep-9015-appx-l.html#d0e307034">365</a></b>. The request must be filed before the Office issues an
                              Office action under 35 U.S.C. 132 or a notice of allowance in the application. The
                              suspension will start on the day that the Office grants the request for deferral of
                              examination. Once the deferral of examination has been granted, the application will
                              not be taken up for action by the examiner until the suspension period expires. For
                              example, if an applicant files a request for deferral of examination under
                              <b><a href="mpep-9020-appx-r.html#d0e321982">37 CFR 1.103(d)</a></b> for the maximum period permitted under the
                              rule in an application that claims priority of a foreign application filed 1/3/00,
                              the action by the Office on the application will be suspended and the application
                              will automatically be placed in a regular new case status on the examiner’s docket on
                              1/4/03 (36 months from the effective filing date of the application, i.e., 1/3/00). 
                           </p>
                           <div class="Section">
                              <h3 class="section1" id="d0e78925">1. &nbsp;&nbsp;Requirements</h3>
                              <p id="d0e78929">Form PTO/SB/37 (reproduced at
                                 the end of this section) may be used to submit a request for deferral of
                                 examination under <b><a href="mpep-9020-appx-r.html#d0e321982">37 CFR
                                       1.103(d)</a></b>.
                              </p>
                              <p id="d0e78935">A request for deferral of
                                 examination under <b><a href="mpep-9020-appx-r.html#d0e321982">37 CFR 1.103(d)</a></b> must
                                 include:
                              </p>
                              <div id="d0e78941" class="List">
                                 <ul style="list-style-type: none;">
                                    <li id="d0e78942" class="nobull">(A) a period of
                                       suspension, in a whole number of months, not extending beyond three years
                                       from the earliest effective filing date (if the request includes no
                                       period of suspension or a period that exceeds the maximum period
                                       permitted under the rule, i.e., beyond 3 years from the earliest
                                       effective filing date, the Office will assume that the maximum period is
                                       requested);
                                    </li>
                                    <li id="d0e78946" class="nobull">(B) the publication fee
                                       set forth in <b><a href="mpep-9020-appx-r.html#d0e315894">37 CFR 1.18(d)</a></b>;
                                       and
                                    </li>
                                    <li id="d0e78953" class="nobull">(C) the processing fee set
                                       forth in <b><a href="mpep-0010-title-page.html#d0e315199">37 CFR
                                             1.17(i)</a></b>.
                                    </li>
                                 </ul>
                              </div>
                              <p id="d0e78960">The Office will not grant a
                                 deferral of examination unless the following conditions are met:
                              </p>
                              <div id="d0e78963" class="List">
                                 <ul style="list-style-type: none;">
                                    <li id="d0e78964" class="nobull">(A) the application must
                                       be 
                                       <ul style="list-style-type: none;">
                                          <li id="" class="nobull">
                                             <p id=""></p>
                                          </li>
                                          <li id="d0e78968" class="nobull">(1) an original
                                             utility or plant application filed under <b><a href="mpep-9020-appx-r.html#d0e318681">37 CFR 1.53(b)</a></b><b id="d0e78973">or</b></li>
                                          <li id="d0e78976" class="nobull">(2) an application
                                             resulting from entry of an&nbsp;international application into the
                                             national stage&nbsp;after compliance with <b><a href="mpep-9020-appx-r.html#d0e329467">37 CFR 1.495</a></b> (the application cannot be a
                                             design application, a reissue application, or a CPA under
                                             <b><a href="mpep-9020-appx-r.html#d0e318681">37 CFR
                                                   1.53(d)</a></b>);
                                          </li>
                                       </ul>
                                    </li>
                                    <li id="d0e78986" class="nobull">(B) the application must
                                       be filed on or after November 29, 2000 (the effective date of the
                                       eighteen month publication provisions of the AIPA); 
                                    </li>
                                    <li id="d0e78990" class="nobull">(C) the applicant has not
                                       filed a nonpublication request under <b><a href="mpep-9020-appx-r.html#d0e325295">37 CFR
                                             1.213(a)</a></b>, <b id="d0e78996">or</b> if a
                                       nonpublication request has been filed in the application, the applicant
                                       must file a request under <b><a href="mpep-9020-appx-r.html#d0e325295">37 CFR
                                             1.213(b)</a></b> to rescind a previously filed
                                       nonpublication request (see the second check box on the form
                                       PTO/SB/37);
                                    </li>
                                    <li id="d0e79003" class="nobull">(D) the application must
                                       be in condition for publication as provided in <b><a href="mpep-9020-appx-r.html#d0e325182">37 CFR
                                             1.211(c)</a></b> (if the application has been forwarded to
                                       the Technology Center by the Office of Patent Application Processing
                                       (OPAP), the application can be assumed to be in condition for
                                       publication); and
                                    </li>
                                    <li id="d0e79010" class="nobull">(E) the Office has not
                                       issued either an Office action under <b><a href="mpep-9015-appx-l.html#d0e303187">35 U.S.C.
                                             132</a></b> (e.g., a restriction, a first&nbsp;Office action on
                                       the merits, or a requirement under <b><a href="mpep-9020-appx-r.html#d0e322262">37 CFR
                                             1.105</a></b>) or a notice of allowance under
                                       <b><a href="mpep-9015-appx-l.html#d0e303440">35 U.S.C.
                                             151</a></b>.
                                    </li>
                                 </ul>
                              </div>
                           </div>
                           <div class="Section">
                              <h3 class="section1" id="d0e79023">2. &nbsp;&nbsp;Improper Request</h3>
                              <p id="d0e79027"> If the request is improper,
                                 the following form paragraphs may be used to notify the applicant of the denial of
                                 the request:
                              </p>
                              <div class="formPara"><a name="fp7.56.02"></a><h1 class="page-title">¶ 7.56.02
                                    &nbsp;&nbsp;
                                      Request for Deferral of Examination under 37 CFR <b><a href="mpep-9020-appx-r.html#d0e321982">1.103(d)</a></b>, Denied
                                 </h1>
                                 <p id="fp-pt-d370e12">Applicant’s request filed on <b id="">[1]</b>, for deferral of examination under 37 CFR <b><a href="mpep-9020-appx-r.html#d0e321982">1.103(d)</a></b> in the application is denied as being improper. <b id="">[2]</b></p>
                                 <p id="fp-pt-d370e24">See MPEP § <b><a href="s709.html#d0e78325">709</a></b>.
                                 </p>
                                 <h3>Examiner Note:</h3>  <ul style="list-style-type: none;">
                                 <li class="nobull">1. In bracket 1, insert the filing date of the request for deferral of examination.</li>
                                 <li class="nobull">2. In bracket 2, insert the reason(s) for denying the request. For example, if appropriate insert --The applicant has not filed
                                    a request under 37 CFR <b><a href="mpep-9020-appx-r.html#d0e325295">1.213(b)</a></b> to rescind the previously filed nonpublication request--; --A first Office action has been issued in the application--; or
                                    --Applicant has not submitted a request for voluntary publication under 37 CFR <b><a href="mpep-9020-appx-r.html#d0e325531">1.221</a></b>--.
                                    
                                    
                                 </li>  </ul>
                              </div>
                           </div>
                           <div class="Section">
                              <h3 class="section1" id="d0e79089">3. &nbsp;&nbsp;Proper Request</h3>
                              <p id="d0e79093">A supervisory patent examiner’s
                                 approval is required for the grant of a deferral of examination in an application.
                                 If the request is proper, the following form paragraph may be used to notify
                                 applicant that the request for deferral has been granted:
                              </p>
                              <div class="formPara"><a name="fp7.54.01"></a><h1 class="page-title">¶ 7.54.01
                                    &nbsp;&nbsp;
                                    Request for Deferral of Examination under 37 CFR <b><a href="mpep-9020-appx-r.html#d0e321982">1.103(d)</a></b>, Granted
                                 </h1>
                                 <p id="fp-pt-d366e12">Applicant’s request filed on <b id="">[1]</b>, for deferral of examination under 37 CFR <b><a href="mpep-9020-appx-r.html#d0e321982">1.103(d)</a></b> in the application has been approved. The examination of the application will be deferred for a period of <b id="">[2]</b> months.
                                 </p>
                                 <h3>Examiner Note:</h3>  <ul style="list-style-type: none;">
                                 <li class="nobull">1. In bracket 1, insert the filing date of the request for deferral of examination.</li>
                                 <li class="nobull">2. In bracket 2, insert the number of months for the deferral.</li>  </ul>
                              </div>
                           </div>
                        </div>
                        <div class="Section">
                           <h2 class="section2" id="d0e79141">D.
                              &nbsp;&nbsp;Termination of Suspension of Action
                           </h2>
                           <p id="d0e79145">Once the request for suspension of
                              action under <b><a href="mpep-9020-appx-r.html#d0e321982">37&nbsp;CFR 1.103</a></b> has been approved,
                              action on the application will be suspended until the suspension period has expired,
                              unless the applicant submits a request for termination of the suspension of action
                              prior to the end of the suspension period. The request for termination of a
                              suspension of action will be effective when an appropriate official of the Office
                              takes action thereon. If the request for termination properly identifies the
                              application and the period of suspension has not expired when the Office acts on the
                              request, the Office will terminate the suspension and place the application on the
                              examiner’s docket. An acknowledgment should be sent to the applicant using the
                              following form paragraph:
                           </p>
                           <div class="formPara"><a name="fp7.54.02"></a><h1 class="page-title">¶ 7.54.02
                                 &nbsp;&nbsp;
                                 Request for Termination of a Suspension of Action, Granted   
                              </h1>
                              <p id="fp-pt-d367e9">Applicant’s request filed on <b id="">[1]</b>, for termination of a suspension of action under 37 CFR <b><a href="mpep-9020-appx-r.html#d0e321982">1.103</a></b>, has been approved. The suspension of action has been terminated on the date of mailing this notice.
                              </p>
                              <h3>Examiner Note:</h3>
                              <p id="fp-pt-d367e20">In bracket 1, insert the filing date of the request for termination of the suspension of action.</p>
                           </div>
                        </div>
                     </div>
                     <div class="Section">
                        <h2 class="section1" id="d0e79185">II.
                           &nbsp;&nbsp;AT THE INITIATIVE OF THE OFFICE
                        </h2>
                        <p id="d0e79189">Suspension of action at the
                           initiative of the Office should be avoided, if possible, because such suspension will
                           cause delays in examination, will increase pendency of the application, and may lead to
                           a shortening of the effective patent term or, conversely, patent term extension, or
                           adjustment, due to the suspension. Once a suspension of action has been initiated, it
                           should be terminated immediately once the reason for initiating the suspension no longer
                           exists, even if the suspension period has not expired.
                        </p>
                        <p id="d0e79192"><b><a href="mpep-9020-appx-r.html#d0e321982">37 CFR 1.103(e)</a></b>
                           provides that the Office will notify applicant if the Office suspends action in an
                           application on its own initiative. Every suspension of action initiated by the Office
                           will be limited to a time period of a maximum of 6 months. An examiner may grant an
                           initial suspension of Office action on his or her own initiative, as in
                           <b><a href="s709.html#d0e79323">MPEP §
                                 709.01</a></b> and <b><a href="mpep-2300.html#d0e237627">MPEP Chapter 2300</a></b>, for
                           a maximum period of 6 months. A notification of suspension must be mailed to the
                           applicant for each Office-initiated suspension of action, even for second or subsequent
                           suspensions, and must include a suspension period (a maximum of 6 months). When the
                           suspension period has expired, the examiner should take up action on the application or
                           evaluate all possibilities for giving an action on the merits. For example, if a
                           reference is still not available after waiting for six months, the examiner should try
                           to find another source for the information or update the search to find another
                           reference that can be used to make a rejection. If, in an extraordinary circumstance, a
                           second or subsequent suspension is necessary, the examiner must obtain the TC director’s
                           approval (see <b><a href="s1003.html#d0e118308">MPEP § 1003</a></b>) and prepare another
                           suspension notification with a suspension period (a maximum of 6 months). The
                           notification for a second or subsequent suspension must be signed by the TC
                           Director.
                        </p>
                        <p id="d0e79207">Suspension of action under
                           <b><a href="mpep-9020-appx-r.html#d0e321982">37
                                 CFR 1.103(f)</a></b> is decided by the TC Director of work group
                           3640.
                        </p>
                        <p id="d0e79213">The following form paragraphs should
                           be used in actions relating to suspension of action at the initiative of the
                           Office.
                        </p>
                        <div class="formPara"><a name="fp7.52"></a><h1 class="page-title">¶ 7.52
                              &nbsp;&nbsp;
                              Suspension of Action, Awaiting New Reference
                           </h1>
                           <p id="fp-pt-d363e9">A reference relevant to the examination of this application may soon become available. <i>Ex parte</i> prosecution is SUSPENDED FOR A PERIOD OF <b id="">[1] </b>MONTHS from the mailing date of this letter.  Upon expiration of the period of suspension, applicant should make an inquiry
                              as to the status of the application.
                           </p>
                           <h3>Examiner Note:</h3>  <ul style="list-style-type: none;">
                           <li class="nobull">1. Maximum period for suspension is six months.</li>
                           <li class="nobull">2. The TC Director must approve all second or subsequent suspensions, see  <b><a href="s1003.html#d0e118308">MPEP § 1003</a></b>.
                           </li>
                           <li class="nobull">3. The TC Director’s signature must appear on the letter granting any second or subsequent suspension.</li>  </ul>
                        </div>
                        <div class="formPara"><a name="fp7.53"></a><h1 class="page-title">¶ 7.53
                              &nbsp;&nbsp;
                              Suspension of Action, Possible Interference
                           </h1>
                           <p id="fp-pt-d364e9">All claims are allowable.  However, due to a potential interference, <i>ex parte</i> prosecution is SUSPENDED FOR A PERIOD OF <b id="">[1]</b> MONTHS from the mailing date of this letter.  Upon expiration of the period of suspension, applicant should make an inquiry
                              as to the status of the application.
                           </p>
                           <h3>Examiner Note:</h3>  <ul style="list-style-type: none;">
                           <li class="nobull">1. Maximum period for suspension is six months.</li>
                           <li class="nobull">2. The TC Director must approve all second or subsequent suspensions, see  <b><a href="s1003.html#d0e118308">MPEP § 1003</a></b>.
                           </li>
                           <li class="nobull">3. The TC Director’s signature must appear on the letter granting any second or subsequent suspension.</li>  </ul>
                        </div>
                        <div class="figure" id="d0e79311"><img src="graphics/709-1.png" alt="Form PTO/SB/37. Request for Deferral of Examination 37 CFR 1.103(d)" width="762" height="896"></div>
                        <div class="figure" id="d0e79316"><img src="graphics/709-2.png" alt="Privacy Act Statement" width="715" height="901"></div>
                     </div>
                     <div class="Section">
                        <h1 class="page-title" id="d0e79323">709.01
                           &nbsp;&nbsp;Overlapping Applications by Same Applicant or Owned by Same
                           Assignee [R-11.2013]
                        </h1>
                        <p id="d0e79331">In general, examiners should not
                           consider <i>ex parte</i> questions which are pending before the Office in
                           <i>inter partes</i> proceedings involving the same applicant. This
                           situation may arise when at least one application or patent of the same applicant that
                           is involved in an interference, derivation proceeding, <i>inter partes</i>
                           reexamination or <i>inter partes</i> review contains claims which overlap
                           with claims of an application (original or reissue) under examination or with claims
                           involved in an <i>ex parte</i> reexamination proceeding. An examiner should
                           consult with the TC Quality Assurance Specialist to determine the appropriate course of
                           action. 
                        </p>
                     </div>
                     <p align="right"><a href="#top">[top]</a></p>
                  </div>
               </div>
               <div>
                  <h1 class="page-title">&nbsp;</h1>
               </div>  </div>
            </div>
         </div>
      </div>
      <div class="yui-b">
         <div id="aside">  <div id="rdms-sub-nav-container" xmlns:bf="http://www.uspto.gov/bf">
            <ul id="sub-nav">
               <li xmlns=""><a href="s701.html">701-Statutory Authority for Examination</a></li>
               <li xmlns=""><a href="s702.html">702-Requisites of the Application</a><ul>
                     <li><a href="s702.html#d0e55492">702.01-Obviously Informal Cases</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s703.html">703-[Reserved]</a></li>
               <li xmlns=""><a href="s704.html">704-Search and Requirements for Information</a><ul>
                     <li><a href="s704.html#d0e55732">704.01-Search</a></li>
                     <li><a href="s704.html#ch700_d222e8_22a5e_f2">704.02 – 704.09-[Reserved]</a></li>
                     <li><a href="s704.html#d0e55758">704.10-Requirements for Information</a></li>
                     <li><a href="s704.html#d0e55923">704.11-What Information May Be Required</a><ul style="list-style-type: none">
                           <li><a href="s704.html#d0e55998">704.11(a)-Examples of Information Reasonably Required</a></li>
                           <li><a href="s704.html#d0e56152">704.11(b)-When May a Requirement for Information Be Made</a></li>
                        </ul>
                     </li>
                     <li><a href="s704.html#d0e56235">704.12-Replies to a Requirement for Information</a><ul style="list-style-type: none">
                           <li><a href="s704.html#d0e56242">704.12(a)-Relationship of Requirement for Information to Duty of Disclosure</a></li>
                           <li><a href="s704.html#d0e56303">704.12(b)-What Constitutes a Complete Reply</a></li>
                           <li><a href="s704.html#d0e56326">704.12(c)-Treatment of an Incomplete Reply</a></li>
                        </ul>
                     </li>
                     <li><a href="s704.html#d0e56409">704.13-Time Periods for Reply</a></li>
                     <li><a href="s704.html#d0e56462">704.14-Making a Requirement for Information</a><ul style="list-style-type: none">
                           <li><a href="s704.html#d0e56472">704.14(a)-Format of the Requirement</a></li>
                           <li><a href="s704.html#d0e57624">704.14(b)-Examiner’s Obligation Following Applicant’s Reply</a></li>
                           <li><a href="s704.html#d0e57713">704.14(c)-Petitions to Requirements Under 37 CFR 1.105</a></li>
                           <li><a href="s704.html#d0e57734">704.14(d)-Relationship to Information Disclosure Statements</a></li>
                        </ul>
                     </li>
                  </ul>
               </li>
               <li xmlns=""><a href="s705.html">705-Patentability Reports</a><ul>
                     <li><a href="s705.html#d0e57821">705.01-Instructions re Patentability Reports</a><ul style="list-style-type: none">
                           <li><a href="s705.html#d0e57831">705.01(a)-Nature of P.R., Its Use and Disposal</a></li>
                           <li><a href="s705.html#d0e57884">705.01(b)-Sequence of Examination</a></li>
                           <li><a href="s705.html#d0e57894">705.01(c)-Counting and Recording P.R.s</a></li>
                           <li><a href="s705.html#d0e57904">705.01(d)-[Reserved]</a></li>
                           <li><a href="s705.html#d0e57921">705.01(e)-Limitation as to Use</a></li>
                           <li><a href="s705.html#d0e57956">705.01(f)-Interviews With Applicants</a></li>
                        </ul>
                     </li>
                  </ul>
               </li>
               <li xmlns=""><a href="s706.html">706-Rejection of Claims</a><ul>
                     <li><a href="s706.html#d0e58202">706.01-Contrasted With Objections</a></li>
                     <li><a href="s706.html#d0e58220">706.02-Rejection on Prior Art</a><ul style="list-style-type: none">
                           <li><a href="s706.html#d0e58605">706.02(a)-Rejections Under 35 U.S.C. 102(a)(1) and (a)(2) and pre-AIA 35 U.S.C. 102(a), (b), or (e); Printed Publication or Patent</a><ul>
                                 <li><a href="s706.html#ch700_d222ef_27c07_2a6">706.02(a)(1)-Determining Whether To Apply 35 U.S.C. 102(a)(1) or 102(a)(2)</a></li>
                                 <li><a href="s706.html#ch700_d222ef_28177_3af">706.02(a)(2)-Determining Whether To Apply Pre-AIA 35 U.S.C. 102(a), (b), or (e)</a></li>
                              </ul>
                           </li>
                           <li><a href="s706.html#d0e58922">706.02(b)-Overcoming a 35 U.S.C. 102 Rejection Based on a Printed Publication or Patent</a><ul>
                                 <li><a href="s706.html#ch700_d222ed_14b69_1df">706.02(b)(1)-Overcoming a 35 U.S.C. 102(a)(1) or 102(a)(2) Rejection Based on a Printed Publication or Patent</a></li>
                                 <li><a href="s706.html#ch700_d222ed_2060e_135">706.02(b)(2)-Overcoming a Pre-AIA 35 U.S.C. 102(a), (b), or (e) Rejection Based on a Printed Publication or Patent</a></li>
                              </ul>
                           </li>
                           <li><a href="s706.html#d0e59190">706.02(c)-Rejections Under 35 U.S.C. 102(a)(1) or pre-AIA 35 U.S.C. 102(a) or (b); Knowledge by Others or Public Use or Sale</a><ul>
                                 <li><a href="s706.html#ch700_d1ff6b_28811_77">706.02(c)(1) -Rejections under 35 U.S.C. 102(a)(1); Public Use or Public Sale</a></li>
                                 <li><a href="s706.html#ch700_d1ff6b_29962_2b6">706.02(c)(2) -Rejections under pre-AIA 35 U.S.C. 102(a) and (b); Public Use or On Sale</a></li>
                              </ul>
                           </li>
                           <li><a href="s706.html#d0e59323">706.02(d)-Rejections Under Pre-AIA 35 U.S.C. 102(c)</a></li>
                           <li><a href="s706.html#d0e59339">706.02(e)-Rejections Under Pre-AIA 35 U.S.C. 102(d)</a></li>
                           <li><a href="s706.html#d0e59404">706.02(f)-Rejection Under pre-AIA 35 U.S.C. 102(e)</a><ul>
                                 <li><a href="s706.html#d0e59437">706.02(f)(1)-Examination Guidelines for Applying References Under Pre-AIA 35 U.S.C. 102(e)</a></li>
                                 <li><a href="s706.html#d0e60667">706.02(f)(2)-Provisional Rejections Under 35 U.S.C. 102(a)(2) or pre-AIA 35 U.S.C. 102(e); Reference Is a Copending U.S. Patent Application</a></li>
                              </ul>
                           </li>
                           <li><a href="s706.html#d0e60927">706.02(g)-Rejections Under Pre-AIA 35 U.S.C. 102(f)</a></li>
                           <li><a href="s706.html#d0e60951">706.02(h)-Rejections Under pre-AIA 35 U.S.C. 102(g)</a></li>
                           <li><a href="s706.html#d0e60975">706.02(i)-Form Paragraphs for Use in Rejections Under 35 U.S.C. 102</a></li>
                           <li><a href="s706.html#d0e62410">706.02(j)-Contents of a 35 U.S.C. 103 Rejection</a></li>
                           <li><a href="s706.html#d0e62510">706.02(k)-Provisional Rejection (Obviousness) Under 35 U.S.C. 103 Using Provisional Prior Art Under Pre-AIA 35 U.S.C. 102(e)</a></li>
                           <li><a href="s706.html#d0e63416">706.02(l)-Rejections Under Pre-AIA 35 U.S.C. 103(a) Using Prior Art Under Only Pre-AIA 35 U.S.C. 102 (e), (f), or (g)</a><ul>
                                 <li><a href="s706.html#d0e63621">706.02(l)(1)-Rejections Under Pre-AIA 35 U.S.C. 103(a) Using Prior Art Under Pre-AIA 35 U.S.C. 102(e), (f), or (g); Prior Art Disqualification
                                       Under Pre-AIA 35 U.S.C. 103(c)</a></li>
                                 <li><a href="s706.html#d0e63867">706.02(l)(2)-Establishing Common Ownership or Joint Research Agreement Under Pre-AIA 35 U.S.C. 103(c)</a></li>
                                 <li><a href="s706.html#d0e64539">706.02(l)(3)-Examination Procedure With Respect to pre-AIA 35 U.S.C. 103(c)</a></li>
                              </ul>
                           </li>
                           <li><a href="s706.html#d0e64785">706.02(m)-Form Paragraphs for Use in Rejections Under 35 U.S.C. 103</a></li>
                           <li><a href="s706.html#d0e65889">706.02(n)-Biotechnology Process Applications; pre-AIA 35 U.S.C. 103(b)</a></li>
                        </ul>
                     </li>
                     <li><a href="s706.html#d0e66074">706.03-Rejections Not Based on Prior Art</a><ul style="list-style-type: none">
                           <li><a href="s706.html#d0e66135">706.03(a)-Rejections Under 35 U.S.C. 101</a></li>
                           <li><a href="s706.html#d0e66605">706.03(b)-Barred by Atomic Energy Act</a></li>
                           <li><a href="s706.html#d0e66656">706.03(c)-Rejections Under 35 U.S.C. 112(a) or pre-AIA 35 U.S.C. 112, First Paragraph</a></li>
                           <li><a href="s706.html#d0e67094">706.03(d)-Rejections Under 35 U.S.C. 112(b) or pre-AIA 35 U.S.C. 112, Second Paragraph</a></li>
                           <li><a href="s706.html#ch700_d1b08a_2849c_65">706.03(e)-Form Paragraphs for Use Relating to 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, Sixth Paragraph</a></li>
                           <li><a href="s706.html#ch700_d222f6_22927_24">706.03(f) - 706.03(j)-[Reserved]</a></li>
                           <li><a href="s706.html#d0e68096">706.03(k)-Duplicate Claims</a></li>
                           <li><a href="s706.html#ch700_d222f6_229eb_304">706.03(l)-[Reserved]</a></li>
                           <li><a href="s706.html#d0e68212">706.03(m)-Nonelected Inventions</a></li>
                           <li><a href="s706.html#ch700_d222f6_22a11_2f3">706.03(n)-[Reserved]</a></li>
                           <li><a href="s706.html#d0e68225">706.03(o)-New Matter</a></li>
                           <li><a href="s706.html#ch700_d222f6_22ae6_255">706.03(p) - 706.03(r)-[Reserved]</a></li>
                           <li><a href="s706.html#d0e68373">706.03(s)-Foreign Filing Without License</a></li>
                           <li><a href="s706.html#ch700_d222f6_22ba6_3c6">706.03(t)-[Reserved]</a></li>
                           <li><a href="s706.html#d0e68440">706.03(u)-Disclaimer</a></li>
                           <li><a href="s706.html#d0e68598">706.03(v)-After Interference or Former Public Use Proceeding</a></li>
                           <li><a href="s706.html#d0e68627">706.03(w)-Res Judicata</a></li>
                           <li><a href="s706.html#d0e68737">706.03(x)-Reissue</a></li>
                        </ul>
                     </li>
                     <li><a href="s706.html#d0e68774">706.04-Rejection of Previously Allowed Claims</a></li>
                     <li><a href="s706.html#d0e68858">706.05-Rejection After Allowance of Application</a></li>
                     <li><a href="s706.html#d0e68872">706.06-Rejection of Claims Copied From Patent</a></li>
                     <li><a href="s706.html#d0e68889">706.07-Final Rejection</a><ul style="list-style-type: none">
                           <li><a href="s706.html#d0e69118">706.07(a)-Final Rejection, When Proper on Second Action</a></li>
                           <li><a href="s706.html#d0e69408">706.07(b)-Final Rejection, When Proper on First Action</a></li>
                           <li><a href="s706.html#d0e69657">706.07(c)-Final Rejection, Premature</a></li>
                           <li><a href="s706.html#d0e69670">706.07(d)-Final Rejection, Withdrawal of, Premature</a></li>
                           <li><a href="s706.html#d0e69716">706.07(e)-Withdrawal of Final Rejection, General</a></li>
                           <li><a href="s706.html#d0e69766">706.07(f)-Time for Reply to Final Rejection</a></li>
                           <li><a href="s706.html#d0e69997">706.07(g)-Transitional After-Final Practice</a></li>
                           <li><a href="s706.html#d0e70778">706.07(h)-Request for Continued Examination (RCE) Practice</a></li>
                        </ul>
                     </li>
                  </ul>
               </li>
               <li xmlns=""><a href="s707.html">707-Examiner’s Letter or Action</a><ul>
                     <li><a href="s707.html#d0e73364">707.01-Primary Examiner Indicates Action for New Assistant</a></li>
                     <li><a href="s707.html#d0e73379">707.02-Applications Up for Third Action and 5-Year Applications</a></li>
                     <li><a href="s707.html#ch700_d2235d_16ab9_dc">707.03-707.04-[Reserved]</a></li>
                     <li><a href="s707.html#d0e73405">707.05-Citation of References</a><ul style="list-style-type: none">
                           <li><a href="s707.html#d0e73580">707.05(a)-Copies of Cited References</a></li>
                           <li><a href="s707.html#d0e73748">707.05(b)-Citation of Related Art and Information by Applicants</a></li>
                           <li><a href="s707.html#d0e73820">707.05(c)-Order of Listing</a></li>
                           <li><a href="s707.html#d0e73839">707.05(d)-Reference Cited in Subsequent Actions</a></li>
                           <li><a href="s707.html#d0e73852">707.05(e)-Data Used in Citing References</a></li>
                           <li><a href="s707.html#d0e74235">707.05(f)-[Reserved]</a></li>
                           <li><a href="s707.html#d0e74267">707.05(g)-Incorrect Citation of References</a></li>
                        </ul>
                     </li>
                     <li><a href="s707.html#d0e74521">707.06-Citation of Decisions, Orders Memorandums, and Notices</a></li>
                     <li><a href="s707.html#d0e74561">707.07-Completeness and Clarity of Examiner’s Action</a><ul style="list-style-type: none">
                           <li><a href="s707.html#d0e74584">707.07(a)-Complete Action on Formal Matters</a></li>
                           <li><a href="s707.html#d0e74650">707.07(b) - 707.07(c)-[Reserved]</a></li>
                           <li><a href="s707.html#d0e74673">707.07(d)-Language To Be Used in Rejecting Claims</a></li>
                           <li><a href="s707.html#d0e74709">707.07(e)-Note All Outstanding Requirements</a></li>
                           <li><a href="s707.html#d0e74734">707.07(f)-Answer All Material Traversed</a></li>
                           <li><a href="s707.html#d0e75512">707.07(g)-Piecemeal Examination</a></li>
                           <li><a href="s707.html#d0e75582">707.07(h)-Notify of Inaccuracies in Amendment</a></li>
                           <li><a href="s707.html#d0e75600">707.07(i)-Each Claim To Be Mentioned in Each Office Action</a></li>
                           <li><a href="s707.html#d0e75644">707.07(j)-State When Claims Are Allowable</a></li>
                           <li><a href="s707.html#d0e75884">707.07(k)-Numbering Paragraphs</a></li>
                           <li><a href="s707.html#d0e75891">707.07(l)-Comment on Examples</a></li>
                        </ul>
                     </li>
                     <li><a href="s707.html#d0e75927">707.08-Reviewing and Initialing by Assistant Examiner</a></li>
                     <li><a href="s707.html#d0e76165">707.09-Signing by Primary or Other Authorized Examiner</a></li>
                     <li><a href="s707.html#d0e76179">707.10-Entry</a></li>
                     <li><a href="s707.html#d0e76189">707.11-Date</a></li>
                     <li><a href="s707.html#d0e76196">707.12-Mailing</a></li>
                     <li><a href="s707.html#d0e76206">707.13-Returned Office Action</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s708.html">708-Order of Examination</a><ul>
                     <li><a href="s708.html#d0e76300">708.01-List of Special Cases</a></li>
                     <li><a href="s708.html#d0e76445">708.02-Petition To Make Special</a><ul style="list-style-type: none">
                           <li><a href="s708.html#d0e76886">708.02(a)-Accelerated Examination</a></li>
                           <li><a href="s708.html#ch700_d1b14c_1b3ba_78">708.02(b)-Prioritized Examination</a></li>
                           <li><a href="s708.html#ch700_d222fb_22824_182">708.02(c)-Patent Prosecution Highway Program</a></li>
                        </ul>
                     </li>
                     <li><a href="s708.html#d0e78312">708.03-Examiner Tenders Resignation</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s709.html">709-Suspension of Action</a><ul>
                     <li><a href="s709.html#d0e79323">709.01-Overlapping Applications by Same Applicant or Owned by Same Assignee</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s710.html">710-Period for Reply</a><ul>
                     <li><a href="s710.html#d0e79409">710.01-Statutory Period</a><ul style="list-style-type: none">
                           <li><a href="s710.html#d0e79563">710.01(a)-Statutory Period, How Computed</a></li>
                        </ul>
                     </li>
                     <li><a href="s710.html#d0e79609">710.02-Shortened Statutory Period and Time Limit Actions Computed</a><ul style="list-style-type: none">
                           <li><a href="s710.html#ch700_d2235d_19d7e_2c1">710.02(a)-[Reserved]</a></li>
                           <li><a href="s710.html#d0e79811">710.02(b)-Shortened Statutory Period: Situations in Which Used</a></li>
                           <li><a href="s710.html#d0e79923">710.02(c)-Specified Time Limits: Situations in Which Used</a></li>
                           <li><a href="s710.html#d0e80029">710.02(d)-Difference Between Shortened Statutory Periods for Reply and Specified Time Limits</a></li>
                           <li><a href="s710.html#d0e80143">710.02(e)-Extension of Time</a></li>
                        </ul>
                     </li>
                     <li><a href="s710.html#ch700_d222fb_259b6_9b">710.03-[Reserved]</a></li>
                     <li><a href="s710.html#d0e80814">710.04-Two Periods Running</a><ul style="list-style-type: none">
                           <li><a href="s710.html#d0e80830">710.04(a)-Copying Patent Claims</a></li>
                        </ul>
                     </li>
                     <li><a href="s710.html#d0e80846">710.05-Period Ending on Saturday, Sunday, or a Federal Holiday</a></li>
                     <li><a href="s710.html#d0e80917">710.06-Situations When Reply Period Is Reset or Restarted</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s711.html">711-Abandonment of Patent Application</a><ul>
                     <li><a href="s711.html#d0e81118">711.01-Express or Formal Abandonment</a></li>
                     <li><a href="s711.html#d0e81477">711.02-Failure To Take Required Action During Statutory Period</a><ul style="list-style-type: none">
                           <li><a href="s711.html#d0e81694">711.02(a)-Insufficiency of Reply</a></li>
                           <li><a href="s711.html#d0e81768">711.02(b)-Special Situations Involving Abandonment</a></li>
                           <li><a href="s711.html#d0e81872">711.02(c)-Termination of Proceedings</a></li>
                        </ul>
                     </li>
                     <li><a href="s711.html#d0e81927">711.03-Reconsideration of Holding of Abandonment; Revival</a><ul style="list-style-type: none">
                           <li><a href="s711.html#d0e81941">711.03(a)-Holding Based on Insufficiency of Reply</a></li>
                           <li><a href="s711.html#d0e81958">711.03(b)-Holding Based on Failure To Reply Within Period</a></li>
                           <li><a href="s711.html#d0e81972">711.03(c)-Petitions Relating to Abandonment</a></li>
                           <li><a href="s711.html#d0e83996">711.03(d)-Examiner’s Statement on Petition To Set Aside Examiner’s Holding</a></li>
                        </ul>
                     </li>
                     <li><a href="s711.html#d0e84017">711.04-Public Access to Abandoned Applications</a><ul style="list-style-type: none">
                           <li><a href="s711.html#d0e84071">711.04(a)-Date of Abandonment</a></li>
                           <li><a href="s711.html#d0e84099">711.04(b)-Ordering of Patented and Abandoned Files</a></li>
                           <li><a href="s711.html#d0e84151">711.04(c)-Notifying Applicants of Abandonment</a></li>
                        </ul>
                     </li>
                     <li><a href="s711.html#d0e84183">711.05-Letter of Abandonment Received After Application Is Allowed</a></li>
                     <li><a href="s711.html#d0e84209">711.06-Abstracts, Abbreviatures, and Defensive Publications</a><ul style="list-style-type: none">
                           <li><a href="s711.html#d0e84305">711.06(a)-Citation and Use of Abstracts, Abbreviatures, and Defensive Publications as References</a></li>
                        </ul>
                     </li>
                  </ul>
               </li>
               <li xmlns=""><a href="s712.html">712-[Reserved]</a></li>
               <li xmlns=""><a href="s713.html">713-Interviews</a><ul>
                     <li><a href="s713.html#d0e84383">713.01-General Policy, How Conducted</a></li>
                     <li><a href="s713.html#d0e84551">713.02-Interviews Prior to First Official Action</a></li>
                     <li><a href="s713.html#d0e84584">713.03-Interview for “Sounding Out” Examiner Not Permitted</a></li>
                     <li><a href="s713.html#d0e84595">713.04-Substance of Interview Must Be Made of Record</a></li>
                     <li><a href="s713.html#d0e84822">713.05-Interviews Prohibited or Granted, Special Situations</a></li>
                     <li><a href="s713.html#d0e84908">713.06-No Inter Partes Questions Discussed Ex Parte</a></li>
                     <li><a href="s713.html#d0e84929">713.07-Exposure of Other Cases</a></li>
                     <li><a href="s713.html#d0e84939">713.08-Demonstration, Exhibits, Models</a></li>
                     <li><a href="s713.html#d0e85001">713.09-Finally Rejected Application</a></li>
                     <li><a href="s713.html#d0e85020">713.10-Interview Preceding Filing Amendment Under 37 CFR 1.312</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s714.html">714-Amendments, Applicant’s Action</a><ul>
                     <li><a href="s714.html#d0e86080">714.01-Signatures to Amendments</a><ul style="list-style-type: none">
                           <li><a href="s714.html#d0e86093">714.01(a)-Unsigned or Improperly Signed Amendment</a></li>
                           <li><a href="s714.html#ch700_d2235d_1ae2a_334">714.01(b)-[Reserved]</a></li>
                           <li><a href="s714.html#d0e86223">714.01(c)-Signed by Attorney or Agent Not of Record</a></li>
                           <li><a href="s714.html#d0e86239">714.01(d)-Amendment Signed by Applicant but Not by Attorney or Agent of Record</a></li>
                           <li><a href="s714.html#d0e86256">714.01(e)-Amendments Before First Office Action</a></li>
                        </ul>
                     </li>
                     <li><a href="s714.html#d0e86906">714.02-Must Be Fully Responsive</a></li>
                     <li><a href="s714.html#d0e87038">714.03-Amendments Not Fully Responsive, Action To Be Taken</a><ul style="list-style-type: none">
                           <li><a href="s714.html#d0e87369">714.03(a)-Supplemental Amendment</a></li>
                        </ul>
                     </li>
                     <li><a href="s714.html#d0e87605">714.04-Claims Presented in Amendment With No Attempt To Point Out Patentable Novelty</a></li>
                     <li><a href="s714.html#d0e87635">714.05-Examiner Should Immediately Review</a></li>
                     <li><a href="s714.html#ch700_d222fd_22993_cc">714.06-[Reserved]</a></li>
                     <li><a href="s714.html#d0e87785">714.07-Amendments Not in Permanent Ink</a></li>
                     <li><a href="s714.html#ch700_d222fd_22ad6_350">714.08 - 714.09-[Reserved]</a></li>
                     <li><a href="s714.html#d0e87824">714.10-Claims Added in Excess of Claims Previously Paid For</a></li>
                     <li><a href="s714.html#d0e87850">714.11-Amendment Filed During Interference Proceedings</a></li>
                     <li><a href="s714.html#d0e87869">714.12-Amendments and Other Replies After Final Rejection or Action</a></li>
                     <li><a href="s714.html#d0e88092">714.13-Amendments and Other Replies After Final&nbsp; Rejection or Action, Procedure Followed</a></li>
                     <li><a href="s714.html#d0e88498">714.14-Amendments After Allowance of All Claims</a></li>
                     <li><a href="s714.html#d0e88602">714.15-Amendment Received in Technology Center After Mailing of Notice of Allowance</a></li>
                     <li><a href="s714.html#d0e88661">714.16-Amendment After Notice of Allowance, 37 CFR 1.312</a><ul style="list-style-type: none">
                           <li><a href="s714.html#d0e88904">714.16(a)-Amendments Under 37 CFR 1.312, Copied Patent Claims</a></li>
                           <li><a href="s714.html#d0e88936">714.16(b)-Amendments Under 37 CFR 1.312 Filed With a Motion Under 37 CFR 41.208</a></li>
                           <li><a href="s714.html#d0e88962">714.16(c)-Amendments Under 37 CFR 1.312, Additional Claims</a></li>
                           <li><a href="s714.html#d0e88985">714.16(d)-Amendments Under 37 CFR 1.312, Handling</a></li>
                           <li><a href="s714.html#d0e89226">714.16(e)-Amendments Under 37 CFR 1.312, Entry in Part</a></li>
                        </ul>
                     </li>
                     <li><a href="s714.html#d0e89305">714.17-Amendment Filed After the Period for Reply Has Expired</a></li>
                     <li><a href="s714.html#d0e89335">714.18-Entry of Amendments</a></li>
                     <li><a href="s714.html#d0e89404">714.19-List of Amendments, Entry Denied</a></li>
                     <li><a href="s714.html#d0e89601">714.20-List of Amendments Entered in Part</a></li>
                     <li><a href="s714.html#d0e89670">714.21-Amendments Inadvertently Entered, No Legal Effect</a></li>
                     <li><a href="s714.html#ch700_d222fd_25939_d3">714.22 - 714.24-[Reserved]</a></li>
                     <li><a href="s714.html#d0e89700">714.25-Discourtesy of Applicant or Attorney</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s715.html">715-Swearing Behind a Reference — Affidavit or Declaration Under 37&nbsp;CFR 1.131(a)</a><ul>
                     <li><a href="s715.html#d0e90633">715.01-37 CFR 1.131(a) Affidavits Versus 37 CFR 1.132 Affidavits</a><ul style="list-style-type: none">
                           <li><a href="s715.html#d0e90674">715.01(a)-Reference Is a Joint Patent or Published Application to Applicant and Another</a></li>
                           <li><a href="s715.html#d0e90725">715.01(b)-Reference and Application Have Common Assignee</a></li>
                           <li><a href="s715.html#d0e90779">715.01(c)-Reference Is Publication of Applicant’s Own Invention</a></li>
                           <li><a href="s715.html#d0e90853">715.01(d)-Activities Applied Against the Claims</a></li>
                        </ul>
                     </li>
                     <li><a href="s715.html#d0e90867">715.02-How Much of the Claimed Invention Must Be Shown, Including the General Rule as to Generic Claims</a></li>
                     <li><a href="s715.html#d0e90984">715.03-Genus-Species, Practice Relative to Cases Where Predictability Is in Question</a></li>
                     <li><a href="s715.html#d0e91142">715.04-Who May Make Affidavit or Declaration Under 37 CFR 1.131(a); Formal Requirements of Affidavits and Declarations</a></li>
                     <li><a href="s715.html#d0e91264">715.05-U.S. Patent or Application Publication Claiming Same Invention</a></li>
                     <li><a href="s715.html#ch700_d222fe_29a2e_240">715.06-[Reserved]</a></li>
                     <li><a href="s715.html#d0e91497">715.07-Facts and Documentary Evidence</a><ul style="list-style-type: none">
                           <li><a href="s715.html#d0e91755">715.07(a)-Diligence</a></li>
                           <li><a href="s715.html#d0e91810">715.07(b)-Interference Testimony Sometimes Used</a></li>
                           <li><a href="s715.html#d0e91830">715.07(c)-Acts Relied Upon Must Have Been Carried Out in This Country or a NAFTA or WTO Member Country</a></li>
                           <li><a href="s715.html#d0e91911">715.07(d)-Disposition of Exhibits</a></li>
                        </ul>
                     </li>
                     <li><a href="s715.html#d0e91930">715.08-Decided by Primary Examiner</a></li>
                     <li><a href="s715.html#d0e91958">715.09-Timely Presentation</a></li>
                     <li><a href="s715.html#d0e92043">715.10-Review of Affidavit or Declaration for Evidence of Prior Public Use or Sale or Failure to Disclose Best Mode</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s716.html">716-Affidavits or Declarations Traversing Rejections, 37 CFR 1.132</a><ul>
                     <li><a href="s716.html#d0e92469">716.01-Generally Applicable Criteria</a><ul style="list-style-type: none">
                           <li><a href="s716.html#d0e92557">716.01(a)-Objective Evidence of Nonobviousness</a></li>
                           <li><a href="s716.html#d0e92626">716.01(b)-Nexus Requirement and Evidence of Nonobviousness</a></li>
                           <li><a href="s716.html#d0e92659">716.01(c)-Probative Value of Objective Evidence</a></li>
                           <li><a href="s716.html#d0e92769">716.01(d)-Weighing Objective Evidence</a></li>
                        </ul>
                     </li>
                     <li><a href="s716.html#d0e92844">716.02-Allegations of Unexpected Results</a><ul style="list-style-type: none">
                           <li><a href="s716.html#d0e92863">716.02(a)-Evidence Must Show Unexpected Results</a></li>
                           <li><a href="s716.html#d0e92965">716.02(b)-Burden on Applicant</a></li>
                           <li><a href="s716.html#d0e93049">716.02(c)-Weighing Evidence of Expected and Unexpected Results</a></li>
                           <li><a href="s716.html#d0e93107">716.02(d)-Unexpected Results Commensurate in Scope With Claimed Invention</a></li>
                           <li><a href="s716.html#d0e93171">716.02(e)-Comparison With Closest Prior Art</a></li>
                           <li><a href="s716.html#d0e93271">716.02(f)-Advantages Disclosed or Inherent</a></li>
                           <li><a href="s716.html#d0e93296">716.02(g)-Declaration or Affidavit Form</a></li>
                        </ul>
                     </li>
                     <li><a href="s716.html#d0e93309">716.03-Commercial Success</a><ul style="list-style-type: none">
                           <li><a href="s716.html#d0e93379">716.03(a)-Commercial Success Commensurate in Scope With Claimed Invention</a></li>
                           <li><a href="s716.html#d0e93437">716.03(b)-Commercial Success Derived From Claimed Invention</a></li>
                        </ul>
                     </li>
                     <li><a href="s716.html#d0e93536">716.04-Long-Felt Need and Failure of Others</a></li>
                     <li><a href="s716.html#d0e93610">716.05-Skepticism of Experts</a></li>
                     <li><a href="s716.html#d0e93635">716.06-Copying</a></li>
                     <li><a href="s716.html#d0e93668">716.07-Inoperability of References</a></li>
                     <li><a href="s716.html#d0e93720">716.08-Utility and Operability of Applicant’s Disclosure</a></li>
                     <li><a href="s716.html#d0e93742">716.09-Sufficiency of Disclosure</a></li>
                     <li><a href="s716.html#d0e93797">716.10-Attribution Affidavit or Declaration to Overcome Rejection Under Pre-AIA 35 U.S.C. 102 or 103</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s717.html">717-Prior Art Exceptions under AIA 35 U.S.C. 102(b)(1) and (2)</a><ul>
                     <li><a href="s717.html#ch700_d1ffd2_23944_3cf">717.01-Affidavit or Declaration Under 37 CFR 1.130</a><ul style="list-style-type: none">
                           <li><a href="s717.html#ch700_d1ffd2_259c8_56">717.01(a) -Declarations or Affidavits under 37 CFR 1.130(a) – Attribution</a><ul>
                                 <li><a href="s717.html#ch700_d1ffd2_25a28_f0">717.01(a)(1) -Evaluation of Declarations or Affidavits under 37 CFR 1.130(a)</a></li>
                              </ul>
                           </li>
                           <li><a href="s717.html#ch700_d1ffd2_272b7_365">717.01(b) -Declarations or Affidavits under 37 CFR 1.130(b) – Prior Public Disclosure</a><ul>
                                 <li><a href="s717.html#ch700_d1ffd2_27375_c6">717.01(b)(1) -Evaluation of Declarations or Affidavits under 37 CFR 1.130(b)</a></li>
                                 <li><a href="s717.html#ch700_d1ffd5_19bbd_19a">717.01(b)(2) -Determining if the Subject Matter of the Intervening Disclosure is the Same as the Subject Matter of the Inventor–Originated
                                       Prior Public Disclosure</a></li>
                              </ul>
                           </li>
                           <li><a href="s717.html#ch700_d1ffd5_1afb1_28b">717.01(c) -Who May Make Affidavit or Declaration; Formal Requirements of Affidavits and Declarations</a></li>
                           <li><a href="s717.html#ch700_d1ffd5_1b0eb_138">717.01(d)-U.S. Patent or Application Publication Claiming Same Invention</a></li>
                           <li><a href="s717.html#ch700_d1ffd5_1b16a_114">717.01(e) -Passed Upon (or Decided by) by Primary Examiner</a></li>
                           <li><a href="s717.html#ch700_d1ffd5_1b223_14b">717.01(f) -Seasonable (or Timely) Presentation</a></li>
                        </ul>
                     </li>
                     <li><a href="s717.html#ch700_d1ffd5_1b424_139">717.02 -Prior Art Exception for Commonly Owned or Joint Research Agreement Subject Matter under AIA 35 U.S.C. 102(b)(2)(C)</a><ul style="list-style-type: none">
                           <li><a href="s717.html#ch700_d1ffd5_1c280_3bb">717.02(a) -Invoking the Prior Art Exception under 35 U.S.C. 102(b)(2)(C)</a></li>
                           <li><a href="s717.html#ch700_d1ffd5_1c4e3_25f">717.02(b) -Evaluating Whether the Prior Art Exception under AIA 35 U.S.C. 102(b)(2)(C) is Properly Invoked</a></li>
                           <li><a href="s717.html#ch700_d1ffd5_1fcbc_170">717.02(c) -Examination Procedure With Respect to the Prior Art Exception under AIA 35 U.S.C. 102(b)(2)(C)</a></li>
                           <li><a href="s717.html#ch700_d1ffd5_20499_a7">717.02(d) -Form Paragraphs With Respect to the Prior Art Exception under AIA 35 U.S.C. 102(b)(2)(C)</a></li>
                        </ul>
                     </li>
                  </ul>
               </li>
               <li xmlns=""><a href="s718.html">718-Affidavit or Declaration to Disqualify Commonly Owned Patent as Prior Art, 37 CFR 1.131(c)</a></li>
               <li xmlns=""><a href="s719.html">719-File Wrapper</a><ul>
                     <li><a href="s719.html#d0e94038">719.01-Papers in Image File Wrapper</a></li>
                     <li><a href="s719.html#d0e94229">719.02-Residence of Inventor Changed</a></li>
                     <li><a href="s719.html#d0e94267">719.03-Classification During Examination</a></li>
                     <li><a href="s719.html#d0e94281">719.04-Index of Claims</a></li>
                     <li><a href="s719.html#d0e94319">719.05-Field of Search</a></li>
                  </ul>
               </li>
               <li xmlns=""><a href="s720.html">720-Public Use Proceedings</a></li>
               <li xmlns=""><a href="s721 - 723.html">721 - 723-[Reserved]</a></li>
               <li xmlns=""><a href="s724.html">724-Trade Secret, Proprietary, and Protective Order Materials</a><ul>
                     <li><a href="s724.html#d0e96255">724.01-Completeness of the Patent File Wrapper</a></li>
                     <li><a href="s724.html#d0e96272">724.02-Method of Submitting Trade Secret, Proprietary, and/or Protective Order Materials</a></li>
                     <li><a href="s724.html#d0e96429">724.03-Types of Trade Secret, Proprietary, and/or Protective Order Materials Submitted Under MPEP § 724.02</a></li>
                     <li><a href="s724.html#d0e96487">724.04-Office Treatment and Handling of Materials Submitted Under MPEP § 724.02</a><ul style="list-style-type: none">
                           <li><a href="s724.html#d0e96564">724.04(a)-Materials Submitted in an Application Covered by 35 U.S.C. 122</a></li>
                           <li><a href="s724.html#d0e96674">724.04(b)-Materials Submitted in Reissue Applications Open to the Public Under 37 CFR 1.11(b)</a></li>
                           <li><a href="s724.html#d0e96779">724.04(c)-Materials Submitted in Reexamination File Open to the Public Under 37 CFR 1.11(d)</a></li>
                        </ul>
                     </li>
                     <li><a href="s724.html#d0e96896">724.05-Petition To Expunge Information or Copy of Papers in Application File</a></li>
                     <li><a href="s724.html#d0e97065">724.06-Handling of Petitions To Expunge Information or Copy of Papers in Application File</a></li>
                  </ul>
               </li>
            </ul>  </div>
         </div>
      </div>  </div>
      

  <div style="text-align:right"> Last Modified: 

     

    03/27/2014 10:10:36 

  </div>

</div>

</div>




<!-- End of footer2.html -->


   </body>
</html>